Capstone Triton Financial Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
FAM
AC
Capstone Triton Financial Group's CLB Position: Q1 2021 in Review
Capstone Triton Financial Group sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 542 shares — an estimated $14K sold.
Capstone Triton Financial Group first reported a position in CLB in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.
- Capstone Triton Financial Group reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
- Capstone Triton Financial Group sold 542 Core Laboratories shares in Q1 2021, an estimated $14K.
- Capstone Triton Financial Group first reported a position in Core Laboratories in Q4 2020 and held it in 1 quarter.
- Capstone Triton Financial Group's Core Laboratories position peaked at $14K in Q4 2020.
- 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.
Based on Capstone Triton Financial Group's 13F filing for Q1 2021, filed 17 May 2021.